№1 / 2021

Activities of RNMOT
Report on the activities of the Russian Scientific Medical Society of Internal Medicine in 2020 		7-10
The best educational practices of 2020: interregional medical «MEDCARE» tournament in I.N. Ulyanov Chuvash State University 		11-12
INVITATION TO DISCUSSION
Samorodskaya I.V., Larina V.N., Vorobyov P.A., Vorobyov A.P.
Prospects for the provision of medical care using remote technologies in the context of the COVID-19 pandemic at the outpatient stage 		13-23
ORIGINAL STUDIES
Mazurov V.I., Gaydukova I.Z., Bashkinov R.A., Fonturenko A.Yu., Petrova M.S., Inamova O.V., Кrylova А.I., Nagirnyak I.M.
Relationship between the use of non-steroidal anti-inflammatory drugs and the formation of damage to the cardiovascular system and kidneys in patients with gout 		24-31
Nilova O.V., Kolbasnikov S.V.
Epicardial obesity and cardiovascular risk in elderly and senile patients with arterial hypertension 		32-38
Gosteva E.V., Vasilieva L.V., Osipova O.A., Starodubtseva I. A., Suslova E.Yu.
Assessment of the impact of pharmacotherapy on the structural and functional heart indices in patients with chronic heart failure with middle range ejection fraction taking into account comorbid pathology 		39-46
Vertkin A.L., Romasenko L.V., Isaev M.R., Khuzina I.A., Navruzova N.Kh., Kukartseva K.V., Chuprina S.Y., Zozik I.V., Khacheva K.K.
The therapy of anxiety and depressive disorders in patients with arterial hypertension: the results of All-Russian open prospective observational clinical study TEATR 		47-57
REVIEWS
Alekseeva L.I.
Analysis of the latest foreign clinical recommendations for the treatment of osteoarthritis 		58-67
Karateev A.E., Lila A.M., Alekseeva L.I.
Management of patients with diseases of the musculoskeletal system during the COVID-19 pandemic 		68-77
Moroz E.V., Karateev A.E.
Proton pump inhibitors and the risk of pneumonia: how dangerous is it to use these drugs during the COVID-19 pandemic? 		78-82
Amirdzhanova V.N., Pogozheva E.Yu.
Questions of preparing patients for joint replacement: what does a therapist need to know? 		83-89
Filatova E.S.
The role of central sensitization in the formation and maintenance of chronic pain in patients with joint diseases 		90-96
Karateev A.E.
Chronic musculoskeletal pain as a global therapeutic problem 		97-107
Eliseev M.S.
Cardiovascular diseases in gout and urate-lowering therapy 		108-115
Poteshkina N.G., Domasheva M.N., Khadgezova A.B., Selivanova G.B., Krylova N.S., Svanadze A.M.
Atrial fibrillation and pregnancy: prevalence, treatment approaches 		116-123
GUIDELINES FOR PRACTITIONERS
Yagoda A.V., Gladkikh N.N., Belotserkovskaya M.I., Mikhaylenko E.M., Bataeva A.S., Dolzhenko T.A., Ushakova O.V.
Case of intravital diagnosis of endocardium separation in patient with post-infarction cardio­sclerosis with formation of subendocardial aneurysm 		124-130
Alieva A.M., Almazova I.I., Baykova I.E., Tsar A.A., Salasar Abrigo G.F., Kislyakov V.A., Pinchuk T.V., Elmurzayeva D.A., Modestova A.V., Ettinger O.A., Totolyan G.G., Kadyrova R.K., Tikhomirova A.S., Reznik E.V., Nikitin I.G.
Clinical case: drug-induced liver injury in a patient 84 years old 		131-139
LECTURE
Lebedev P.A., Garanin A.A.
Is there an alternative to multi-target fixed combinations for primary prevention of cardiovascular disease? 		140-146
ACTUAL ISSUES OF PHARMACOTHERAPY
Toroptsova N.V., Dobrovolskaya O.V., Nikitinskaya O.A.
Fractures prevention in clinical practice in a view of modern approaches for the diagnosis and treatment of osteoporosis 		147-153
Babak S.L., Gorbunova M.V., Malyavin A.G.
Strategy of mucolytic therapy: ambroxol 		154-161
Orlova S.V., Nikitina E.A., Prokopenko E.V., Vodolazkaya A.N.
Iron deficiency management: diet, dietary supplements or drugs? 		162-171
Syrov A.V., Minushkina L.O.
Choosing the optimal thiazide-like diuretic in patients with arterial hypertension 		172-180
Shcherbakova O.N., Pyko A.A., Safonkina O.S., Kuosa T.A., Likhotkina E.A., Popilov M.A.
Assessment of an integrated approach to the treatment of comorbid pathology using the enterosorption method 		181-187
Spivak L.G.
Advantages of alpha1-adrenoblocker tamsulosin (Omnik® OKAS®) as a first-line drug for prostate adenoma patients treatment 		188-193
OUTSTANDING FIGURES OF RUSSIAN MEDICINE
To the birthday of academician A.G. Chuchalin 		194
To the anniversary of L.B. Lazebnik 		195-196

Бионика Медиа